Takeda

Osaka | Japan

Treatment | Medication

Champion

https://www.takeda.com/newsroom/newsreleases/2020/takeda-initiates-development-of-a-plasma-derived-therapy-for-covid-19/

Takeda initiates the development of a potential covid-19 treatment, an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19

Loading startups...